{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:05:39Z","timestamp":1791266739770,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/hco.0b013e3283512035","type":"journal-article","created":{"date-parts":[[2012,2,10]],"date-time":"2012-02-10T09:17:33Z","timestamp":1328865453000},"page":"273-280","source":"Crossref","is-referenced-by-count":38,"title":["Pulmonary hypertension and right heart failure in heart failure with preserved left ventricular ejection fraction"],"prefix":"10.1097","volume":"27","author":[{"given":"Vincent F.M.","family":"Segers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk L.","family":"Brutsaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles W.","family":"De Keulenaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210204","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1751-7133.2010.00192.x","article-title":"Differentiating pulmonary arterial and pulmonary venous hypertension and the implications for therapy.","volume":"16","author":"Dadfarmay","year":"2010","journal-title":"Congest Heart Fail"},{"key":"R2-12-20210204","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pcad.2011.06.003","article-title":"Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.","volume":"54","author":"Haddad","year":"2011","journal-title":"Prog Cardiovasc Dis"},{"key":"R3-12-20210204","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1742-1241.2010.02524.x","article-title":"Modulating the nitric oxide: cyclic GMP pathway in the pressure-overloaded left ventricle and group II pulmonary hypertension.","volume":"64","author":"Lindman","year":"2010","journal-title":"Int J Clin Pract Suppl"},{"key":"R4-12-20210204","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1152\/physrev.00017.2002","article-title":"Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.","volume":"83","author":"Brutsaert","year":"2003","journal-title":"Physiol Rev"},{"key":"R6-12-20210204","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/hrt.2009.169052","article-title":"Novel strategies in diastolic heart failure.","volume":"96","author":"Paulus","year":"2010","journal-title":"Heart"},{"key":"R7-12-20210204","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pcad.2006.08.010","article-title":"Cardiac dysfunction in heart failure: the cardiologists love affair with time.","volume":"49","author":"Brutsaert","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"key":"R8-12-20210204","first-page":"275","article-title":"Heart failure with a preserved ejection fraction: what is in a name J Am Coll C","volume":"58","author":"Maurer","year":"2011","journal-title":"ardiol"},{"key":"R9-12-20210204","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jcmg.2009.12.011","article-title":"Heart failure with normal ejection fraction: the complementary roles of echocardiography and CMR imaging.","volume":"3","author":"Leong","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"R10-12-20210204","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2011.02.055","article-title":"Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction.","volume":"58","author":"Haykowsky","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R11-12-20210204","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jjcc.2009.07.006","article-title":"Concentric left ventricular hypertrophy brings deterioration of systolic longitudinal, circumferential, and radial myocardial deformation in hypertensive patients with preserved left ventricular pump function.","volume":"55","author":"Mizuguchi","year":"2010","journal-title":"J Cardiol"},{"key":"R12-12-20210204","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"R13-12-20210204","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cardfail.2010.01.003","article-title":"Pulmonary hypertension in heart failure.","volume":"16","author":"Guglin","year":"2010","journal-title":"J Card Fail"},{"key":"R14-12-20210204","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1751-7133.2010.00184.x","article-title":"Determinants of right ventricular failure in patients admitted with acute left heart failure.","volume":"16","author":"Berkowitz","year":"2010","journal-title":"Congest Heart Fail"},{"key":"R15-12-20210204","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.amjcard.2010.02.039","article-title":"Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction.","volume":"106","author":"Leung","year":"2010","journal-title":"Am J Cardiol"},{"key":"R16-12-20210204","first-page":"1711","article-title":"Heart failure with preserved ejection fraction: invasive solution to diagnostic confusion J Am Coll C","volume":"55","author":"Lam","year":"2010","journal-title":"ardiol"},{"key":"R17-12-20210204","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-4682-8-14","article-title":"Modeling left ventricular diastolic dysfunction: classification and key indicators.","volume":"8","author":"Luo","year":"2011","journal-title":"Theor Biol Med Model"},{"key":"R18-12-20210204","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/hrt.2010.212787","article-title":"Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction.","volume":"97","author":"Borlaug","year":"2011","journal-title":"Heart"},{"key":"R19-12-20210204","doi-asserted-by":"crossref","first-page":"807084","DOI":"10.1155\/2010\/807084","article-title":"Physiologic basis and pathophysiologic implications of the diastolic properties of the cardiac muscle.","volume":"2010","author":"Ferreira-Martins","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"R20-12-20210204","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"30","author":"Members","year":"2009","journal-title":"Eur Heart J"},{"key":"R21-12-20210204","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2010.04.040","article-title":"Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction.","volume":"56","author":"Maeder","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R22-12-20210204","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/hr.2010.16","article-title":"Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.","volume":"33","author":"Yamanaka","year":"2010","journal-title":"Hypertens Res"},{"key":"R24-12-20210204","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation"},{"key":"R25-12-20210204","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCULATIONAHA.111.038885","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction.","volume":"124","author":"Waxman","year":"2011","journal-title":"Circulation"},{"key":"R26-12-20210204","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/ATVBAHA.109.202028","article-title":"Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline.","volume":"30","author":"Caruso","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R27-12-20210204","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1161\/ATVBAHA.111.226670","article-title":"Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation.","volume":"31","author":"Davis-Dusenbery","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R28-12-20210204","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20101812","article-title":"Role for miR-204 in human pulmonary arterial hypertension.","volume":"208","author":"Courboulin","year":"2011","journal-title":"J Exp Med"},{"key":"R29-12-20210204","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.echo.2011.04.005","article-title":"Right ventricular myocardial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction.","volume":"24","author":"Morris","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"R30-12-20210204","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00395-009-0017-3","article-title":"Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension.","volume":"104","author":"Correia-Pinto","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"R31-12-20210204","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCOUTCOMES.109.854877","article-title":"A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association Get With the Guidelines Program.","volume":"3","author":"Peterson","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R32-12-20210204","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejim.2010.10.004","article-title":"Mortality rates and modes of death in heart failure patients with reduced versus preserved systolic function.","volume":"22","author":"Zafrir","year":"2011","journal-title":"Eur J Intern Med"},{"key":"R33-12-20210204","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.","volume":"53","author":"Lam","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R34-12-20210204","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1093\/eurheartj\/ehq245","article-title":"Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure.","volume":"31","author":"Damy","year":"2010","journal-title":"Eur Heart J"},{"key":"R35-12-20210204","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","article-title":"Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.","volume":"53","author":"Damman","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R36-12-20210204","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R37-12-20210204","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.110.954388","article-title":"Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.","volume":"123","author":"Borlaug","year":"2011","journal-title":"Circulation"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HCO.0b013e3283512035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:53:25Z","timestamp":1620953605000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001573-201205000-00012"}},"subtitle":["pathophysiology and natural history"],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e3283512035","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}